Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

FDA-authorized alternatives to brand-name weight loss medications gain traction, offering cheaper options for patients.

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

The startup will be headed by CEO Ron Renaud, who previously led Cerevel Therapeutics — a developer of drugs for neurological conditions — and oversaw its acquisition by AbbVie in an $8.7 billion deal ...

A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...

In a leadership shakeup, the diet company says CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...